Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Methamphetamine Abuse: early-phase trial registry
7 of 16 indexed Methamphetamine Abuse trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 7 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Methamphetamine Abuse: 16 US clinical trials tracked, 7 recruiting.
Methamphetamine Abuse is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Affect Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition methamphetamine-abuse
OPEN 7 | RECR 44% | LATE 1 | EARLY 6 | RANK #1060 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Distress Syndrome (44% recruiting · 32 trials)
Methamphetamine Abuse lists 7 open slots (44% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Methamphetamine Abuse on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Methamphetamine Abuse is recruiting below its size-band peers.
7 of 16 indexed trials (43.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Methamphetamine Abuse trials is spread across many organizations.
Affect Therapeutics accounts for 2 of 16 trials (12.5%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Methamphetamine Abuse enrolment sits around 80 participants.
Median target enrolment is 80 among the 16 trials that report a genuine target (sentinel values excluded). 9 of those (56.3%) plan for fewer than 100 participants.
-
Methamphetamine Abuse research is mostly interventional.
16 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
Wake Forest University Health Sciences
NCT04927143
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
National Institute on Drug Abuse (NIDA)
NCT06233799
Ketamine for Methamphetamine Use Disorder
University of Texas Southwestern Medical Center
NCT06496750
Mood and Decision-making in Methamphetamine Use Disorder
Laureate Institute for Brain Research
NCT06410196
rTMS for Craving in Methamphetamine Use Disorder
Oregon Health and Science University
NCT03470480
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Clear Scientific
NCT06721494
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
Carilion Clinic
NCT06372288
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
Oregon Health and Science University
NCT05700994
Contingency Management for Drug Use: Does Age Matter?
Wake Forest University Health Sciences
NCT05521854
Exercise in Methamphetamine Use Disorder Upregulation and Neural Function
University of California, Los Angeles
NCT03709667
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
Affect Therapeutics
NCT05206175
Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
Affect Therapeutics
NCT05266716
Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use
Friends Research Institute
NCT03864653
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
University of Kentucky
NCT01967381
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
University of California, Los Angeles
NCT01011829
Buspirone as a Candidate Medication for Methamphetamine Abuse
University of Kentucky
NCT01843205
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Methamphetamine Abuse records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Methamphetamine Abuse trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Methamphetamine Abuse page
16 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Methamphetamine Abuse trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Affect Therapeutics sponsors the most Methamphetamine Abuse trials on record, review their full trial history before evaluating a specific study. See Affect Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Methamphetamine Abuse condition card totals 16 registered trials; most-linked intervention Methamphetamine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.